{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-018744","form_type":"8-K","ticker":"PEPG","cik":"0001835597","company_name":"PepGen Inc.","filed_at":"2022-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.342906+00:00","generated_at":"2026-06-23T08:05:51.557096+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"PepGen appoints former Acceleron CEO Habib Dable to Board of Directors","bullets":["Habib Dable appointed to fill newly created Board vacancy, effective September 20, 2022.","Dable previously led Acceleron (CEO) through blockbuster launch and $11B sale to Merck in 2021.","Initial option award of 22,686 shares vesting over 4 years; annual cash retainers of $35,000 (Board) and $4,000 (committee).","Dable brings 30 years' biotech and pharma experience; also serves on Blueprint Medicines and Albireo boards.","Appointment supports PepGen's clinical development of PGN-EDO51 for Duchenne muscular dystrophy."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-018744","json":"https://secwatch.observer/filing/0000950170-22-018744.json","markdown":"https://secwatch.observer/filing/0000950170-22-018744.md","text":"https://secwatch.observer/filing/0000950170-22-018744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835597/000095017022018744/0000950170-22-018744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835597/000095017022018744/pepg-20220920.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T08:05:51.557096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"45b25d87bb","claim":"Habib J. Dable was appointed as Director at PepGen Inc..","evidence_excerpt":"Effective September 20, 2022, the Board of Directors (the “Board”) of PepGen Inc. (“PepGen”) on the recommendation of the Nominating and Corporate Governance Committee of the Board, unanimously appointed Habib J. Dable to fill a newly created vacancy on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835597/000095017022018744/0000950170-22-018744-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}